Rasmus Hoeg, M.D.

Rasmus Tetens Hoeg, M.D.


Internal Medicine



  • Associate Physician
To see if Rasmus Tetens Hoeg is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Medical Center

2315 Stockton Blvd.
Sacramento, CA 95817
Driving Directions

Primary Phone:
800-2-UCDAVIS (800-282-3284)

UC Davis Comprehensive Cancer Center

4501 X Street, 2nd Floor
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Fax: 916-703-5265
Physician Referrals: 800-4-UCDAVIS (800-482-3284)


Hematology and Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center


B.A., University of Copenhagen, Copenhagen Denmark 1998


Internal Medicine, Gundersen Lutheran Medical Foundation, La Crosse WI 2006-2008


Hematology, University of Copenhagen, Copenhagen Denmark 2009-2013

Board Certifications

American Board of Internal Medicine, 2008

Danish Board of Health - Hematology, 2013

Danish Board of Health - Internal Medicine, 2013

Professional Memberships

American College of Physicians

Danish Medical Association

Danish Society of Hematology

Danish Society of Internal Medicine

Select Recent Publications

R. T. Hoeg, J. A. Lee, M. A. Mathiason, K. Rokkones, S. L. Serck, K. L. Crampton, A. Emmel, A. J. Jumonville, E. A. Severson, R. S. Go: Outcome of phase II oncology clinical trial abstracts presented at annual meeting of the American Society of Clinical Oncology (ASCO). Am J Clin Oncol. 2009 Jun;32(3):253-7.

R.T. Hoeg, A.M. Skau, P. Nørgaard, P.B. Hansen: ”Complete Remission of diffuse large B-Cell Lymphoma After Eradication of Helicobactor Pylori.” J of the Danish Medical Association. 2011 173:2425-6

Raghavendra M, Hoeg RT, Bottner WA, Agger WA. Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care. Wisconsin Medical Journal. 2014 Apr;113(2):53-8. 

R.T. Hoeg, A. Andersen, E.B. Leinøe, H. Birgens: “Measuring the Impact of a Restrictive Transfusion Guideline in Patients with Acute Myeloid Leukemia” Vox Sanguinis 2013 Jul:105(1):81-4